Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone I Strasser

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Drug and Alcohol Review|August 2, 2024
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)Paul J Clark, Patricia C Valery, Simone I Strasser, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2024
Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in AustraliaEmily Nash, Amanda Nicoll, Nicholas Batt, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2025
Surviving Hepatitis C-Understanding Death and Survival Beyond CurePaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Transplantation Direct|April 20, 2023
The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New ZealandJess Howell, Avik Majumdar, Michael Fink, et al.
Hepatology Communications|July 19, 2021
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Mazen Noureddin, et al.
Transplantation|April 25, 2017
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant CandidatesNorah A Terrault, Geoff W McCaughan, Michael P Curry, et al.
Transplantation|April 25, 2017
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant RecipientsNorah A Terrault, Marina Berenguer, Simone I Strasser, et al.
Scandinavian Journal of Gastroenterology|May 11, 2016
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world studyAdam Doyle, Philip Marsh, Raghubinder Gill, et al.
Alimentary Pharmacology & Therapeutics|April 12, 2019
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsAmanda J Nicoll, Stuart K Roberts, Ricky Lim, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Drug and Alcohol Review|August 2, 2024
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)Paul J Clark, Patricia C Valery, Simone I Strasser, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2024
Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in AustraliaEmily Nash, Amanda Nicoll, Nicholas Batt, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2025
Surviving Hepatitis C-Understanding Death and Survival Beyond CurePaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Transplantation Direct|April 20, 2023
The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New ZealandJess Howell, Avik Majumdar, Michael Fink, et al.
Hepatology Communications|July 19, 2021
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Mazen Noureddin, et al.
Transplantation|April 25, 2017
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant CandidatesNorah A Terrault, Geoff W McCaughan, Michael P Curry, et al.
Transplantation|April 25, 2017
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant RecipientsNorah A Terrault, Marina Berenguer, Simone I Strasser, et al.
Scandinavian Journal of Gastroenterology|May 11, 2016
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world studyAdam Doyle, Philip Marsh, Raghubinder Gill, et al.
Alimentary Pharmacology & Therapeutics|April 12, 2019
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsAmanda J Nicoll, Stuart K Roberts, Ricky Lim, et al.
Pageof 17